Vijay Kasturi
Hoofd Techniek/Wetenschap/O&O bij CG ONCOLOGY, INC.
Vermogen: 47 603 $ op 30-04-2024
Profiel
Vijay Kasturi is currently the Chief Medical Officer at CG Oncology, Inc. Prior to this, he was the Vice President-Clinical Development at AVEO Pharmaceuticals, Inc. from 2021 to 2023, the Head-Medical Affairs at EMD Serono, Inc. from 2015 to 2020, and the Senior Vice President-Scientific Affairs at FerGene, Inc. from 2020 to 2021.
Kasturi received his undergraduate degree from the University of Illinois and his doctorate from Rush Medical College.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
CG ONCOLOGY, INC.
0.00% | 25-03-2024 | 1 315 ( 0.00% ) | 47 603 $ | 30-04-2024 |
Actieve functies van Vijay Kasturi
| Bedrijven | Functie | Begin |
|---|---|---|
| CG ONCOLOGY, INC. | Hoofd Techniek/Wetenschap/O&O | 01-09-2023 |
Eerdere bekende functies van Vijay Kasturi
| Bedrijven | Functie | Einde |
|---|---|---|
| AVEO PHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-08-2023 |
FerGene, Inc.
 FerGene, Inc. BiotechnologyHealth Technology FerGene, Inc. provides gene therapy solutions to urologists. The company is headquartered in Cambridge, MA. | Hoofd Techniek/Wetenschap/O&O | 01-03-2021 |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Corporate Officer/Principal | 01-03-2020 |
Opleiding van Vijay Kasturi
| Rush Medical College | Doctorate Degree |
| University of Illinois | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CG ONCOLOGY, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
AVEO Pharmaceuticals, Inc.
 AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380 and AV-353. The company was founded by Ronald A. DePinho, Lynda Chin, and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA. | Health Technology |
FerGene, Inc.
FerGene, Inc. BiotechnologyHealth Technology FerGene, Inc. provides gene therapy solutions to urologists. The company is headquartered in Cambridge, MA. | Health Technology |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
